ArticleFrontiers in surgery2025
The strategic use of embolization in treating infantile fibrosarcoma-related heart failure: a case report.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Infantile fibrosarcoma (IFS) represents the most common non-rhabdomyosarcoma soft tissue tumor, with 80% of diagnoses under the first year of life. In contrast with adult fibrosarcoma, IFS has lower risks of metastasis, better long-term survival rate, and higher chemosensitivity. Conservative surgery, in association with chemoradiotherapy in case of metastasis or recurrence, usually represents the gold standard treatment. Case: We examined the case of a 2-month-old female patient affected by retroperitoneal congenital fibrosarcoma, which had caused high-flow heart failure (HFHF) due to its hypervascularization and multiple arteriovenous fistulas. Given the complexity of the case and its atypical vascularization, after multidisciplinary discussion, we decided to perform an endovascular approach rather than a surgical one, aiming to interrupt pathological flow to this abdominal mass. The procedure was well tolerated with fast improvement in both clinical and ultrasound markers of heart failure. Conclusion: This is the first instance of arteriographic application for the management of HFHF caused by hypervascularized retroperitoneal IFS that we are aware of. In conclusion, we advise using this approach because of its safety and effectiveness, even though it necessitates a high level of experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.